Atlas Trials

A Phase II Study of Sunitinib Versus Dacarbazine in the Treatment of Patients With Metastatic Uveal Melanoma

Clinical trial NCT01551459 · COMPLETED

Trial details

NCT number
NCT01551459
Sponsor
The Clatterbridge Cancer Centre NHS Foundation Trust
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Uveal Melanoma
Start date
2010-10-01
Primary completion
2017-09-01
Enrollment
124

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.